Non-invasive spinal cord electrical stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial

Chet Moritz,Edelle C. Field-Fote,Candace Tefertiller,Ilse van Nes,Randy Trumbower,Sukhvinder Kalsi-Ryan,Mariel Purcell,Thomas W. J. Janssen,Andrei Krassioukov,Leslie R. Morse,Kristin D. Zhao,James Guest,Ralph J. Marino,Lynda M. Murray,Jill M. Wecht,Markus Rieger,Jared Pradarelli,Amanda Turner,Jessica D’Amico,Jordan W. Squair,Gregoire Courtine

DOI: https://doi.org/10.1038/s41591-024-02940-9

IF: 82.9

2024-05-21

Nature Medicine

Abstract:Cervical spinal cord injury (SCI) leads to permanent impairment of arm and hand functions. Here we conducted a prospective, single-arm, multicenter, open-label, non-significant risk trial that evaluated the safety and efficacy of ARC EX Therapy to improve arm and hand functions in people with chronic SCI. ARC EX Therapy involves the delivery of externally applied electrical stimulation over the cervical spinal cord during structured rehabilitation. The primary endpoints were safety and efficacy as measured by whether the majority of participants exhibited significant improvement in both strength and functional performance in response to ARC EX Therapy compared to the end of an equivalent period of rehabilitation alone. Sixty participants completed the protocol. No serious adverse events related to ARC EX Therapy were reported, and the primary effectiveness endpoint was met. Seventy-two percent of participants demonstrated improvements greater than the minimally important difference criteria for both strength and functional domains. Secondary endpoint analysis revealed significant improvements in fingertip pinch force, hand prehension and strength, upper extremity motor and sensory abilities and self-reported increases in quality of life. These results demonstrate the safety and efficacy of ARC EX Therapy to improve hand and arm functions in people living with cervical SCI. ClinicalTrials.gov identifier: NCT04697472.

biochemistry & molecular biology,cell biology,medicine, research & experimental

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the permanent impairment of arm and hand functions caused by cervical spinal cord injury (SCI). Specifically, the paper introduced a multi - center, open - label, non - significant - risk trial aiming to evaluate the safety and effectiveness of ARC EX therapy in improving the arm and hand functions of patients with chronic SCI. ARC EX therapy involves the external application of electrical stimulation to the cervical spinal cord during a structured rehabilitation process.

The main research objectives of the paper include:
1. **Safety assessment**: Evaluate the safety of ARC EX therapy, especially whether there will be serious adverse events related to the treatment.
2. **Efficacy assessment**: Evaluate the effect of ARC EX therapy in improving the strength and functional performance of the arm and hand, mainly by comparing the significant improvement of most participants after receiving ARC EX therapy with that after only receiving rehabilitation training.

The research results show that among the 60 participants who completed the protocol, no serious adverse events related to ARC EX therapy were reported, and 72% of the participants showed improvements exceeding the minimum important difference criteria in the strength and function areas. In addition, secondary endpoint analysis showed significant improvements in fingertip pinch force, hand grip force and strength, upper - limb motor and sensory abilities, and self - reported quality of life.

These results indicate that ARC EX therapy is safe and effective in improving the arm and hand functions of patients with chronic cervical SCI.